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1. INTRODUCTION AND JUSTIFICATION 
 
               Esophageal resection and reconstruction remain a major 
therapeutic challenge for surgeons involved in the care of patients with 
benign and malignant disease of esophagus. Despite major advances in 
postoperative care, operative mortality rates worldwide remain high. Much 
of the operative mortality is related to complications of anastomotic leak. 
 
               In a majority of esophageal surgeries, the anastomosis involves 
another segment of the esophagus, stomach, jejunum or colon. Anastomoses 
in operations of the stomach like total gastrectomy or proximal gastrectomy 
also involve the esophagus. 
 
               One of the commonest complications encountered in patients after 
the above operations are an anastomotic leak. These leaks can lead to severe 
morbidity, increased hospital stay and cost and increased mortality. The 
crucial factors in the management of anastomotic leak are to recognize it 
earlier even at a sub clinical stage and act accordingly. Conservative 
management like delaying oral feeds and drainage techniques can be 
employed. However, rapidly progressing clinical scenario mandates 
aggressive approach. 
 
                  Contrast esophagography is the investigation of choice for 
detecting sub clinical anastomotic leaks when done from 7th to 10th 
postoperative days. Barium or water soluble contrasts are being used for the 
same. Our institution routinely performs thin barium contrast studies 
between the 7th to 10th postoperative day. Due to its hygroscopic property, 
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water soluble contrast agents causes dilution of the contrast, thereby 
decreasing its sensitivity and specificity. Barium is more sensitive than water 
soluble contrast agents but is known to cause complications such as barium 
peritonitis and can interfere with repeat scans. Moreover, various studies 
show that the numbers of false negatives are high. 
 
                     Technetium scans are being used for diagnosis and evaluation 
of esophageal motility disorders and gastroesophageal reflux disease. There 
is no data of its use in detection of sub clinical anastomotic leaks in current 
literature. This study is to evaluate the diagnostic efficacy of technetium 
scans in detecting sub clinical leaks in comparison to barium contrast 
studies. It also aims at evaluating the reliability, limitations, disadvantages 
and complications of a Technetium sulphocolloid scan. 
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                2. AIMS OF THE STUDY 
 
  
 
To evaluate the diagnostic efficacy and feasibility of Technetium 
sulphocolloid scans in comparison to esophageal contrast studies in 
diagnosis of sub clinical anastomotic leaks following esophageal 
anastomosis. 
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           3. OBJECTIVES OF THE STUDY 
 
 
 
1. To prospectively evaluate the feasibility of technetium sulphocolloid 
studies in the diagnosis of sub clinical anastomotic leaks. 
 
2. To quantify the agreement that technetium sulphocolloid scans have 
with contrast studies in diagnosis of sub clinical anastomotic leaks. 
 
3. To evaluate advantages and disadvantages of technetium 
sulphocolloid studies in terms of reliability, patient acceptance and 
cost in comparison to contrast studies.  
 
4. To characterize Tc-99m sulphocolloid scan findings that would 
describe a sub clinical anastomotic leak. 
 
5. To correlate patient dependant surgical factors with development of 
anastomotic leaks. 
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 4.1  Microstructural anatomy of esophagus 
 
              The esophagus is a mucosa-lined muscular tube that lacks a serosa 
and is surrounded by a layer of loose fibroalveolar adventitia. Beneath the 
adventitia is a layer of longitudinal muscle, overlying an inner layer of 
circular muscle. Between the two muscular layers is a thin intramuscular 
septum of connective tissue that contains the blood vessels and ganglion 
cells (Auerbach plexus). Both the longitudinal and circular muscle layer of 
the upper third of the esophagus are striated whereas the layers of the lower 
third are smooth. The fatty and relatively thick submucosa permits 
considerable mobility of the esophageal mucosa1. The submucosa contains  
             
                               Fig 4.1 Histology of esophagus 
the mucous glands, blood vessels, the Meissner neural plexus and an 
extensive lymphatic network. The esophageal mucosa consists of squamous 
epithelium except for the distal 1 to 2 cm, which is junctional columnar 
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epithelium. Occasionally, ectopic gastric mucosa may be found throughout 
the length of the esophagus2 
 
4.2 Blood supply and venous drainage of esophagus 
 
            Esophagus is supplied by 
numerous segmental arteries, all of which 
contribute to the extensive capillary 
network. The cervical esophagus receives 
blood from the superior thyroid artery as 
well as the inferior thyroid artery of the 
thyrocervical trunk, with both sides 
communicating through  collateral 
vessels.                                                              Fig 4.2  Arterial blood supply of  
                                                                                                        esophagus 
             The major blood supply of the thoracic esophagus is from four to six 
aortic esophageal arteries, supplemented by collateral vessels from the 
inferior thyroid, intercostal and bronchial, inferior phrenic and left gastric 
arteries2. The aortic esophageal arteries terminate in fine capillary networks 
before they actually penetrate the esophageal muscle layer. After penetrating 
and supplying the muscle layers of the esophagus, the esophageal capillary 
network runs longitudinally in the submucosa. Therefore, the mucosa 
receives poor blood supply. This entails that rough handling or wide 
mobilization of the esophagus may imperil its blood supply, especially over 
its main extent where the aortic branches are distributed in a segmental 
manner3. They are slender, tenuous vessels and this makes it possible to 
mobilize the intrathoracic esophagus by blind digital dissection from the 
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suprasternal notch above and from the esophageal hiatus below during 
certain cases of esophagectomy3. 
 
           The veins of the cervical esophagus drain into the inferior thyroid 
vein and then, the brachiocephalic veins. The veins in the left side of the 
thoracic esophagus drain into the brachiocephalic vein via the left 
hemiazygous system. On the right side, the drainage is through the azygous 
system into the superior vena cava. At the cardio esophageal junction, 
venous drainage of the esophagus may be into the coronary, splenic, 
retroperitoneal and inferior phrenic veins which connect with the portal and 
caval systems. In portal hypertension, the cardio esophageal junction is the 
site of esophageal varices2. 
 
             Anastomosis of the esophagus to any other part of the 
gastrointestinal tract such as stomach, small bowel or colon is prone to 
leakage from the suture line. This is because of its poor mucosal blood 
supply, the absence of a serosal covering and the friability of the mucosal 
layers2. It is particularly important to include the mucosal layer in suturing 
the esophagus. Most surgeons use an ‘all-coats’ interrupted suture when 
anastomosing the esophagus3.  
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4.3  Esophageal operations 
                      Esophageal operations are some of the most major procedures 
of the gastrointestinal tract. The postoperative morbidity and mortality rates 
remain high in spite of the advance in perioperative and postoperative care. 
The mortality rates are as high as 8%. 
 
                      Esophageal carcinoma continues to be challenge to the surgeon 
and oncologist in treatment. The classical presentation is one of 
progressively increasing dysphagia, initially to solids and later to liquids, 
associated with loss of weight and appetite. Advanced cases may also 
present with hematemesis, hoarseness of voice and metastatic symptoms. 
Diagnosis is made by esophagoscopy and endoscopic biopsy. As with most 
other malignant conditions, there are 3 modalities of treatment – surgery, 
chemotherapy or radiotherapy; however, despite numerous clinical trials, no 
treatment modality has proved superior. In the absence of metastatic disease, 
an esophagectomy can be performed in patients who are able to tolerate the 
procedure. A gastric pull-up is the preferred technique of reconstruction 
unless the stomach is extensively involved with tumor. In advanced disease, 
only palliative therapy is indicated which include chemoradiotherapy or 
procedures like esophageal dilatation or stenting. 
 
                     The definitive surgeries for esophageal carcinoma involve 
esophageal resection with restoration of esophageal continuity. Factors such 
as general debility, malnutrition, cardiac risk, multisystem dysfunction, liver 
failure, infection, invasion of a vital structure or metastatic disease 
influences the outcome of treatment and chances of tolerating a surgical 
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procedure4. At best, only 50% of patients are eligible for a curative resection 
at presentation5. The lymphatic drainage is extensive, both within the 
esophageal wall and in the surrounding mediastinal tissues. As a result, 
longitudinal spread of the esophageal carcinoma may be extensive and 
tumors may be multicentric. Tumor recurs at the resection margin in 10% of 
patients who have had a 6 to 8 cm margin of normal esophagus removed. 
Since 1970, the reported 5-year survival rates for patients undergoing 
esophagectomy have risen from 10% to 15% to a high of 35%. This is  
secondary to refinements in surgical techniques and risk management, 
improved anesthesia and critical care management and an emphasis on 
nutrition by enteral or parenteral routes6. Despite these improvements in 
surgical outcome, the overall survival rates for carcinoma esophagus has 
changed little. 
                    There are four types of esophagectomy (transthoracic, enbloc, 
transhiatal and video-assisted), with no particular technique shown to have 
any survival advantage. 
 
                   In transhiatal esophagectomy, the entire thoracic esophagus is 
dissected through a widened hiatus and reconstructed with the stomach 
anastomosed to the remaining cervical esophagus above the level of the 
clavicles. The overall in-hospital mortality for transhiatal esophagectomy is 
5.7% versus 9.2% for transthoracic esophagectomy with no significant 
difference in 3 and 5-year survival7. Advocates of transhiatal esophagectomy 
report a low operative mortality of 2 to 8% and a low anastomotic leak rate 
of 5 to 7.9%8,9. Orringer and coauthors10 reviewed their 22 year experience 
with transhiatal esophagectomy in 1085 patients. They reported hospital 
mortality of 4% an average blood loss of less than 700 ml. Anastomotic leak 
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occurred in 13% of patients. A modified technique of reconstructing the GI 
tract by switching to side to side staple esophagogastric anastomosis has 
reduced the leak rate to less than 3%11. 
 
                  The advantages of the transhiatal esophagectomy approach is that 
include (1) a thoracotomy is avoided (2) an intrathoracic esophageal 
anastomosis is avoided ( if a cervical esophagogastric anastomotic leak does 
occur, it is easily drained and rarely causes mediastinitis or fatal 
complications) and (3) no intraabdominal or intrathoracic gastrointestinal 
suture lines are present. The surgical stapler is used to fashion a gastric tube 
from the stomach and the stomach is pulled up through the posterior 
mediastinum and is anastomosed (hand sewn or stapled) to the cervical 
esophagus12. 
 
            Critics of transhiatal esophagectomy object to the limited exposure 
afforded by the hiatus to the intrathoracic esophagus. The limited exposure 
potentially increases the risk of uncontrolled hemorrhage by injury to the 
azygos vein, the pulmonary veins or the aortic arch and precludes a complete 
mediastinal lymph node dissection for purposes of staging and potential 
cure. A review of the literature with a meta-analysis, however, has shown 
that operative blood loss is significantly less during transhiatal than 
transthoracic esophagectomy7. Contraindications include evidence of tumor 
invasion of the pericardium, aorta or tracheo-bronchial tree13.  Pulmonary 
complications are more common in transthoracic. Transhiatal cervical 
anastomosis predisposes to a higher rate of leaks (13.6% for transhiatal 
versus 7.2% for transthoracic). However, majority of leaks are detected by 
postoperative barium swallows and resolve spontaneously7. Side-to-side 
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stapler technique for the anastomosis decreases the incidence of leaks. 
Decreased traction on recurrent laryngeal nerve decreases incidence of 
hoarseness. Other complications include wound infection, pneumothorax, 
esophageal stricture and delayed gastric emptying12. 
 
                   Transthoracic esophagectomy may be performed via the 
following incisions – left or right thoraco-abdominal incision, separate 
posterolateral thoracic incision and abdominal incision (Ivor-Lewis 
esophagectomy) and cervical, posterolateral thoracic and abdominal incision 
(Mckeown’s esophagectomy). A transthoracic surgery allows complete 
lymph node dissection under direct vision and complete resection of tumor 
mass and adjacent tissue staging of patient is better, however with possibly 
higher perioperative morbidity.  Unfortunately, a combined thoracic and 
abdominal operation in a debilitated patient may lead to respiratory 
insufficiency, resulting from postoperative incisional pain and an inability to 
breathe deeply that requires prolonged mechanical ventilatory assistance. 
This increases mortality due to increased risk of ARDS14. Although 
disruption of an intrathoracic esophageal anastomosis is reported less 
frequently than a cervical anastomotic leak from a transhiatal 
esophagectomy, the consequences, including mediastinitis and sepsis, are 
fatal in up to 40% of patients. The operative mortality varies significantly 
depending on the centre, ranging from 14% to 2.2%13. 
  
                        En Bloc esophagectomy involves radical resection of 
esophagus and lymph nodes along with an envelope of normal tissue, spleen, 
celiac nodes, posterior pericardium, azygos vein, thoracic duct and adjacent 
diaphragm. With this aggressive surgery, operative mortality ranges from 
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5.1% to 11%, and is not significantly different from the other approaches15. 
The two major complications are the same- anastomotic leaks and 
respiratory complications. With this technique, the 5-year survival rate is 40 
to 55 %16. 44 patients with transmural adenocarcinoma who underwent 
enbloc esophagectomy had an overall actuarial 5-year survival of 26%, with 
the presence and number of lymph node metastasis, the most important 
predictors of survival16. 
 
                  Thoracoscopic esophagectomy has 3 stages: the first is in the 
thoracoscopic dissection of the thoracic esophagus. The second is the 
laparoscopic mobilization of the intended gastric conduit and the third is the 
cervical anastomosis. Studies reporting on thoracoscopic esophagectomy 
have indicated an operative mortality between 0 and 13.5%. The morbidity 
has been reported to be 27 to 55%. Major causes of complications include 
respiratory disorders, anastomotic leak, chylothorax and laryngeal nerve 
injury4. Although, technically feasible, the success of thoracoscopic 
esophagectomy is highly dependant on the experience of the surgeon with no 
current technique considered standard. Thoracoscopic esophagectomy has 
not been shown to reduce the length of hospitalization or complications 
relative to open surgical procedures. Randomized trials with longer follow 
up are required to fully evaluate the procedure12. 
 
                           After portion of the esophagus is removed or after complete 
esophagectomy, a conduit must be established for alimentary continuity. The 
stomach, colon and jejunum have all been successfully used as esophageal 
substitutes, most often using the posterior mediastinum or retrosternal 
routes. The stomach is the conduit of choice because of ease in mobilization 
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and rich blood supply. A higher incidence of mortality is noted with the use 
of the colon because of the necessity for three anastomosis eg. 
Coloesophagostomy, colojejunostomy and colocolostomy. The colon is used 
if the patient has undergone a partial or total gastrectomy previously or if the 
tumor involves the stomach to preclude a 5 cm margin. Jejunal loops can 
also be used but their limited vascular supply restricts mobility and length12. 
 
                     Another esophageal pathology that requires major esophageal 
surgery is caustic injury to the esophagus. Initial management is usually 
conservative but many of these patients present at a later date with stricture 
of the esophagus and in most cases the stomach is also affected. The 
treatment of choice is esophageal dilatations but if there are more than 2 
failed dilatations, the probability of further dilatations being helpful, is very 
minimal. The alternative management plan for these patients is a colon 
bypass either via a substernal tunnel or via the posterior mediastinum using 
side-to-side anastomosis between the cervical esophagus and left or right 
colon. Such patients are seen to have a low nutritional status because of their 
limitation in oral feeds. Anastomotic leakage is the most common 
complication in the postoperative period1. 
 
                      Carcinoma stomach involving the fundus and the GE junction 
require a total gastrectomy with esophagojejunal anastomosis. A Roux-en-Y 
loop of jejunum is commonly used for this anastomosis. This part of the 
esophagus due to its proximity to the highly vascular stomach is a well 
vascularised anastomosis and therefore the overall incidence of leak is only 
7.5%17.    
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4.4  Classification of fistulae 
 
                  A new classification of anastomotic fistulas of 
esophagojejunostomy after total extended gastrectomy for advanced gastric 
carcinoma is presented. In a group of 230 consecutive patients submitted to 
total gastrectomy within a 10-year period, there were 20 patients with Type I 
fistula (8.8%) and 18 cases with Type II (7.8%). Type I or subclinical fistula 
corresponded to a local leakage around the anastomosis, with no septic 
complications, which heals with prolongation of enteral feeding up to 20 
days after surgery. The mortality rate was 5% in this group. Type II or 
clinical leakage corresponded to patients with early septic manifestations 
after surgery, in whom the methylene blue test was positive, that is, 
immediate appearance of the stain in any drain was observed after oral 
ingestion, confirmed by radiological studies. The mortality rate in this group 
was 78%. Resuturing of the fistula was a complete failure. Cervical lateral 
esophagostomy produced complete healing in two cases. Parenteral and 
enteral feeding, antibiotics and successful surgical drainage are measured 
that can provide good results in these cases18. 
 
4.5  Anastomotic leak 
 
                     The overall incidence of anastomotic leaks after 
esophagectomy ranges from 12% to 30% as according to several studies. 
This wide range shows the involvement perioperative and intra-operative 
factors that play a role in the development of anastomotic leaks. The pre 
operative factors include presence of other co morbidities19, poor nutritional 
status, low hematocrit and  neoadjuvant chemotherapy19. Intraoperative 
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factors include conduit ischaemia19, experience of the surgeon20, cervical 
anastomosis21, estimated blood loss per milliliter21, the anastomosis being 
performed via a retrosternal or subcutaneous route as opposed to an 
intrathoracic route22, the use of colonic interposition as opposed to gastric 
pedicle22, performing a manual anastomosis as opposed to a mechanical 
anastomosis22 and employing an end to end anastomosis as opposed to an 
end to side anastomosis using a mechanical technique22.Using stapled 
anastomosis, microvascular technique, a staged operation based on the 
preoperative risk analysis, and improvement in pre- and postoperative 
management, the incidence of anastomotic leakage could be decreased from 
35% to 14%, and hospital mortality, from 9% to 2%. The occurrence of 
ARDS in the postoperative period was associated with increased chance of 
anastomotic leak21. The use of thoracic epidural analgesia and early 
nutritional rehabilitation were shown to decrease the incidence of 
anastomotic leakage. 
 
               According to Wormuth et al, average rates of ischemic 
complications for stomach, colon, and jejunum are 3.2%, 5.1%, and 4.2%, 
respectively. Most reports that compare outcomes using different esophageal 
conduits demonstrate similar findings'. Davis and colleagues compared 
results with colon versus gastric conduit esophageal reconstruction. They 
found that operative mortality, anastomotic leaks, and conduit ischemia rates 
were all lower for the stomach than for the colon. Specifically, ischemia of 
the stomach conduit was 0.5%, compared with 2.4% for the colon conduit. 
Moorehead and Wong, in a large series of 760 esophagectomy patients in 
whom the stomach, colon, or jejunum was used for reconstruction, 
demonstrated that the stomach had the lowest incidence of conduit ischemia 
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(1%), followed by jejunum (11.3%), then colon (13.3%). Some of the factors 
they identified as correlating with the risk of ischemia include length of 
conduit, technique of stomach graft preparation, whether anastomosis is in 
the neck or chest, and route of passage of the conduit23.  
 
                   Mansour and colleagues compared their results using bowel 
interposition (either colon or jejunum) to reconstruct the resected esophagus. 
The authors report an overall mortality of 5.9%, and 3% conduit ischemia. 
All ischemia was noted in the colon conduits harvested from the left side. 
No ischemic complications were noted from jejunal segments.  
 
                    Anastomotic leaks can be divided according to the level of the 
leaks into 3 types – cervical, thoracic or mediastinal and abdominal. Of 
these, cervical anastomotic leaks are the most common but are easily 
detected and managed. Thoracic leaks are less common but have very high 
incidence of morbidity and mortality. Abdominal leaks are very rare in 
esophageal surgeries when compared to cervical and thoracic. 
 
                   Cervical anastomotic leaks presents with disruption of the 
cervical wound and obvious discharge along with fistula formation. There 
may be initially a fluctuant swelling at the region of the leak. This can be 
confirmed by giving some water and observing for an increase in the volume 
of discharge or an increase in the size of the swelling. Patient may also have 
mild fever, leucocytosis, dysphagia or sticking sensation at the throat. 
 
                     After completion of a cervical esophageal anastomosis, the 
neck wound is closed loosely in with only four or five 4-0 sutures over a 
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1/4th inch Penrose drain placed adjacent to the anastomosis. If an 
anastomotic leak does occur, the neck wound is opened at the bed side in its 
entirety and gentle wound packing with gauze is initiated. The size of the 
leak can be estimated by having the patient drink water and evaluating the 
amount that escapes from the neck wound with a disposable bedside suction 
catheter. Generally, within several days of opening the wound, the drainage 
diminishes considerably and the patient may resume oral intake while 
maintaining steady gentle pressure over the wound to occlude the fistula. 
Passage of tapered Maloney dilators (Nos 40 and 46) at the bedside during 
the first week after drainage of the cervical fistula ensures that no element of 
obstruction from either local edema or spasm contributes to continued 
drainage of fistula. Passage of esophageal dilator before the fistula has 
closed does not damage the anastomosis further and in fact is followed by 
total closure of the fistula in 2 to 5 days. More than 98% of cervical 
esophagogastric anastomotic leaks are small and respond to the open 
drainage and packing as described. The majority of cervical anastomotic 
leaks heal spontaneously by 2 to 3 weeks. A small proportion, however, are 
associated with catastrophic complications – major gastric tip necrosis 
necessitating take down of the anastomosis, construction of cervical 
esophagostomy and resection of nonviable stomach; vertebral body 
osteomyelitis; epidural abscess with resultant paraplegia; pulmonary micro 
abscesses from internal jugular vein abscess; and tracheooesophagogastric 
anastomotic fistula12. 
 
                When disruption of an intrathoracic esophageal anastomosis 
occurs during the first 10 days after operation, the clinical picture is quite 
characteristic. The typical symptoms of mediastinitis (fever, chest pain, 
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tachycardia, tachypneoa, respiratory distress, peripheral cyanosis, 
vasoconstriction, hypertension and shock) associated with a chest Xray that 
demonstrated hydrothorax or pneumothorax suggest the diagnosis. This 
should nonetheless be documented with a contrast study. An occasional 
small (less than one cm), contained, closed anastomotic leak detected on 
routine postoperative barium swallow in an otherwise asymptomatic patient 
may require no treatment. In most cases however, anastomotic disruption 
warrant immediate re-exploration, irrigation of the chest and mediastinum, 
repair of the fistula if possible and chest tube drainage. A localized 
anastomotic leak with viable adjacent tissue may be amenable to direct 
suture repair. Reinforcement with a pedicled anterior mediastinal fat or 
intercostal muscle flap, pleura or omentum should be carried out. 
Decompression of stomach with nasogastric tube, placement of a 
jejunostomy tube for nutritional support and appropriate antibiotics complete 
the therapy. A barium swallow examination should be performed 10 days 
later to be certain that healing has occurred, and the chest tube should be 
removed before this time. If breakdown of the anastomosis occurs again, the 
goal is to establish a controlled esophago-pleural cutaneous fistula. It may be 
necessary to perform a rib resection in order to position a large bore drainage 
tube adjacent to the fistula and ensure that all drainage from the esophageal 
leak can flow freely out of the chest. Gastric contents that are aspirated 
through the nasogastric tube can be returned to the alimentary tract through 
the jejunostomy tube to minimize electrolyte imbalance and to simplify fluid 
and electrolyte replacement12. 
 
                  If on re-exploration of the chest, for a disrupted esophageal 
anastomosis, extensive local necrosis of the tissue with a major anastomotic 
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dehiscence is found, there is little recourse but to take down the anastomosis, 
resect the nonviable stomach, and return it to the abdomen. Only nonviable 
distal esophagus should be resected. The proximal end of the divided 
intrathoracic esophagus, however, should not be oversewn and left in the 
infected mediastinum while a diverting lateral cervical esophagostomy is 
carried out. Disruption of the intrathoracic esophageal suture line is not only 
likely but if subsequent reconstruction is possible, management of the 
remaining segment of intrathoracic esophagus presents a considerable 
technical problem. The best alternative is to circumferentially mobilize the 
esophagus well into the neck through the thoracic incision and after the 
thoracotomy is closed, turn the patient supine and construct a formal end 
esophagostomy. As indicated earlier, the submucosal collateral circulation of 
the esophagus is excellent and most of the length of the thoracic esophagus 
will remain viable so long as at least one inferior thyroid artery remains 
intact. Therefore, after delivering the divided thoracic esophagus out of the 
neck incision, viable esophagus should not be discarded to “tailor” the 
remaining esophagus for a standard cervical esophagostomy. Rather, the 
maximum length of remaining esophagus should be preserved to facilitate 
later reconstruction. This is achieved by developing a subcutaneous tunnel 
on the anterior chest wall and constructing an anterior thoracic 
esophagostomy. An esophagostomy stoma placed on the relatively flat upper 
anterior chest wall is much more easily cared for by the patient because a 
stomal appliance is more readily adapted to this location than to the usual 
site of a standard cervical esophagostomy. A feeding jejunostomy is, of 
course, required until later esophageal reconstruction can be performed12. 
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                 When colon or jejunum has been used to replace the esophagus 
and necrosis of the graft is documented at re-exploration for anastomotic 
leak, there is similarly little recourse but to remove the nonviable graft and 
insert a feeding tube. If the patient survives the sequelae of the mediastinal 
sepsis, later reconstruction can be considered. 
 
                 Abdominal leaks are intermediate in their presentation. They may 
present at a later date than intrathoracic leaks. These may produce a 
peritonitis–like picture with fever, abdominal pain, guarding and tenderness. 
X-ray may show gas under the diaphragm. The incidence of these type of 
leaks are much less when compared to the other two and are associated with 
total gastrectomies and esophageal surgeries with anastomosis near the 
gastroesophageal junction. 
 
                   Page et al reviewed retrospectively 23 patients who developed 
anastomotic leakage, out of 389 patients undergoing oesophagectomy with 
gastric interposition. The presentation, diagnosis, and treatment of the leaks, 
and patient outcomes were analysed. Leaks occurred from 3 to 23 
(median=7.5) days after surgery. Clinical features included fever (57%), 
leucocytosis (52%), dysphagia (4%), coughing bile (4%), wound infection 
(13%), pneumothorax (35%), pleural effusion (70%) and septicaemia (70%). 
All but one leak was due to variable degree of gastric tip necrosis. Surgical 
treatment (resection of necrotic stomach and either immediate or staged re-
anastomosis, or end-esophageal exteriorisation) was the primary treatment in 
17 patients of whom 15 survived to discharge. Two out of the 6 patients 
treated non-surgically died. Gastric tip necrosis was by far the most common 
cause24.  
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              Esophageal anastomotic leak is a potentially life threatening 
complication of esophagectomy and esophagogastrectomy. Alanezi et al  
reviewed 307 patients undergoing esophagectomy and esophagogastrectomy 
for benign or malignant disease over a 10-year period (1989-1999), who 
developed esophageal anastomotic leaks, were reviewed.  Twenty-three 
(7.5%) developed esophageal anastomotic leaks. Eight of these patients 
(35%) died. Factors predictive of death included age (died, 72.8+/-8.3 years; 
survived, 65.3+/-8.8 years; p=0.063), location of anastomosis (cervical, 3/9 
died; thoracic, 5/14 died; p=0.91), leak presentation (clinical, 6/12 died; 
contrast study, 2/11 died; p=0.11), time of leak (<7 days, 3/5 died; > or =7 
days, 5/18 died; p=0.18), presence of gastric necrosis (necrosis, 3/3 died; no 
necrosis, 5/20 died; p=0.019), and treatment (surgical, 4/4 died; 
conservative, 4/19 died; p=0.005). Gastric necrosis is an important predictor 
of subsequent death. Advanced age, early postoperative (<7 days) leakage, 
and clinically apparent signs of leakage may be predictive of death but these 
factors did not reach statistical significance in this study25.  
 
            The management of anastomotic leakage of the oesophago-
jejunostomy after total gastrectomy for gastric carcinoma was reviewed in a 
retrospective study done by Lang H and Piso P et al. Over a 30-year period, 
a total of 1114 oesophago-jejunostomies were performed during total 
gastrectomy for gastric cancer. In 83 cases (7.5%) in this series, a leak of the 
oesophago-jejunostomy was diagnosed. Frequency of anastomotic leakage 
was independent of the type of reconstruction and of surgical radicality. 
Management was conservative in 58 cases (69.9%), with placement of a 
naso-jejunal tube along the anastomoses and with percutaneous drainage of 
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intraabdominal abscesses. In 25 patients re-operation with resuturing of the 
anastomoses or surgical drainage of an abscess was performed. Mortality 
was 11/58 (19%) after conservative treatment of the anastomotic leakage 
and 16/25 (64%) after re-operation. It was concluded that conservative 
management with a naso-intestinal tube and percutaneous drainage of 
intraabdominal abscesses is a realistic line of management for anastomotic 
leaks. Re-operation results in a high morbidity and should only be 
considered when conservative management does not succeed17.       
 
4.6  Anastomotic stricture 
                       Although management of cervical anastomotic leak is usually 
conservative, the long term sequelae of a cervical leak are significant. As 
many as 50% of cervicoesophagogastric anastomotic leaks result in an 
anastomotic stricture as healing occurs and this represents an unsatisfactory 
outcome of an operation that is intended to provide  comfortable 
swallowing. The implications are similar in patients who survive an 
intrathoracic anastomotic leak.  In their collective review of 46,692 patients 
undergoing an esophagectomy for cancer, Mueller and associates26 reported 
that the incidence of anastomotic leakage with an intrathoracic 
esophagogastric anastomosis was not significantly different for a one-
layer(12%) versus a 2-layer(12%) anastomosis. There was also no difference 
for an anastomosis that was performed manually(11%) versus one performed 
with an EEA surgical stapler. On the other hand, in a series of 580 
esophageal anastomoses, Fok et al27 found that a single layer manually sewn 
anastomosis was associated with a 5% incidence of leak compared with 
3.8% in those with a circular stapled technique(p=0.69). However, stapled 
anastomosis were associated with a higher number of strictures. 
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                    In reviewing the complications of transhiatal esophagectomy in 
1,353 patients, Kataria et al28 reported a mean incidence of cervical 
anastomotic leak of 15% and the same number (15%) of patients developed 
anastomotic strictures. In a series reported by Dewar et al29, a 17% incidence 
of anastomotic leak and 31% incidence of anastomotic stricture in 169 
patients undergoing a cervical esophagogastric anastomosis There was 
statistical significance between anastomotic stricture and a prior anastomotic 
leak(P=0.001). In a review of 131 patients undergoing a transhiatal 
esophagectomy for carcinoma, the Mayo Clinic group reported a   25% 
incidence of cervical leaks30. In another collective review, cervical 
anastomotic leaks  occurred in 5 to 26% of patients undergoing a transhiatal 
esophagectomy with cervical esophagogastric anastomosis. Of this, a series 
of 10 to 15% of the patients developed anastomotic strictures31. Anastomotic 
leak rate averaged 13% in the more than 1000 transhiatal esophagectomy 
patients at the University of Michigan, and nearly half of these patients 
developed subsequent anastomotic strictures10. The prevention of an 
anastomotic leak is the key to a successful outcome in these patients. 
According to recent published data, side to side stapled cervical 
esophagogastric anastomosis has been associated with an anastomotic leak 
rate of less than 3%. This has dramatically reduced the need for late 
postoperative anastomotic dilatations in patients.                          
                   
                     From each of the above studies, it becomes clear that many 
leaks lead to anastomotic strictures causing the same symptom that he 
presented with.  
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4.7  Diagnosis of subclinical anastomotic leaks 
 
               The diagnosis of anastomotic leaks still poses a diagnostic 
challenge in itself. Anastomotic leaks are one of the most common 
complication contributing to a major part of the mortality and morbidity 
esophageal operations. Clinically obvious leaks do not require further 
studies for confirmation. But subclinical anastomotic leaks need a routine 
screening test done. Subclinical anastomotic leaks, if not diagnosed, can 
progress to a clinical leak. Moreover, the subclinical leaks that do not 
progress into clinically evident leaks may develop anastomotic strictures. 
 
               Esophageal conduit necrosis is an uncommon but disastrous 
complication of esophageal surgery. Careful selection of patients for 
surgery, preoperative evaluation of the proposed conduit, and meticulous 
operative technique are the best defenses against conduit ischemia. 
Postoperatively, surgeons should have a high index of suspicion for this 
complication. Unexplained tachycardia, respiratory failure, leukocytosis, or 
any evidence for graft or anastomotic leak should prompt a search for 
conduit ischemia. The diagnosis is made by contrast esophagography, 
endoscopy, or direct operative inspection23. 
 
            Contrast esophagography is done routinely in many centres including 
ours from the 7th to 10th postoperative day. A negative study indicates start 
of oral feeds. If a subclinical leak is reported, the patient is either managed 
conservatively or a decision for aggressive management, as mentioned 
earlier, is considered. Contrast esophagography can be done either with 
barium suspension or water soluble contrast agent. 
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4.7.1 Barium contrast media 
 
                 The first known study of GI tract involved stomach of a guinea 
pig using lead acetate. Subsequently, various studies were done using 
bismuth subnitrites which were useful in showing the anatomical details of 
the GI tract but the reduction of subnitrite into nitrate produced severe long 
term toxicity. It was then that barium studies became popular and till today, 
barium contrast is being used for most of radiological contrast studies. 
 
                 The ideal characteristics of the barium contrast media used are the 
following. The barium suspension must be dense yet flow readily. It must 
not be too fluid or it drains too quickly, leaves too thin a coat on the mucosa 
and is poorly recorded on the radiograph. The suspension is somewhat 
thixotropic so that barium remains suspended when agitation or stirring is 
stopped. The yield point must be low so that the suspension flows readily 
under the influence of gravity. Any cake at the bottom of the suspension 
must form slowly and resuspend easily. It should not foam and should coat 
the mucosa evenly without artifacts. It must adhere and remain firmly 
attached to the damp mucosal wall for a considerable length of time. It must 
form mucosal coating films that accommodate themselves to extensive 
dimensional films without cracking. These films must remain flexible and 
even must resist the formation of weak points. Surface defects must level 
themselves out. The suspension, as it coats the mucosa, must not drag and 
flow too slowly or it increases the radiation burden on the patient and the 
radiologist. It must be non toxic. The suspension must do all this at large and 
varying ranges of pH and patient hydration. It must do all of the above in the 
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presence of flocculating substances such as sodium chloride, mucin and 
blood and in other difficult extremes of patient's internal environment32            
          
                   The barium ion is highly toxic. Hecht claims that the oral intake 
by human adults of more than 3 mg /kg body weight of soluble barium salts 
may be considered harmful. However, barium sulphate is very poorly 
soluble in water. Barium causes a constipating tendency for all patients. 
When ingested in a toxic dose, the soluble barium salts result in a relatively 
acute muscular paralysis and lead to death. Patients with barium toxicity 
may present with hypertensive uropathy unresponsive to phentolamine. 
There is profound muscle weakness associated with hypokalemia33. The 
erythrocyte potassium level is increased because of intracellular movement 
of potassium. Sulfhaemoglobin may be present. Involvement of muscles of 
respiration can produce a respiratory acidosis. Therapy consists of 
aggressive intravenous administration of potassium, marked diuresis to help 
clear barium and where necessary, ventilation assistance32. 
 
                  Other important complications include bowel perforation, barium 
peritonitis or barium intravasation. Barium may enter the peri-intestinal 
tissues34, resulting in extensive  fibrosis and barium granuloma formation. 
Perforation can be difficult to detect during fluoroscopy. Contrast medium 
can spread throughout the peritoneal cavity or be localized in the pelvis. 
Mortality from colonic perforation during a barium enema is probably over 
50%. The morbidity and mortality depend on the amount of contrast in the 
peritoneal cavity. Barium sulphate and stool are more toxic as a combination 
than either alone35. However, even sterile barium sulphate in the peritoneal 
cavity of dogs, produce hemorrhagic peritonitis. The long term sequel of 
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barium sulfate peritonitis36 include extensive bowel adhesions and barium 
sulfate granulomas. Ureteral obstruction has been reported. There is dense 
fibrosis around the barium sulfate particles. The granulomas may contain 
large cells with refringent granules of barium sulphate in the cytoplasm. 
Some of the barium sulphate can enter the lymphatics. Another potential 
complication is barium intravasation37. This may occur anywhere due to 
gastrointestinal ulceration. Most of the reported cases with intravastion 
died32. 
 
4.7.2 Water soluble contrast medium-  
 
               Water soluble contrast was introduced for the examination of the 
GI tract in 1955. It became unpopular after it was shown by Nelson and 
colleagues that it causes dehydration especially in infants. Vest and Margulis 
reported in 1962 on the advantages of water soluble contrast agents in 
differentiating between adynamic ileus and mechanical small bowel 
obstruction, particularly in the postoperative patients. Presently, most 
radiologists as well as studies agree that water soluble contrast agents are the 
contrast media of choice in demonstrating the site of perforation of the GI 
tract and for injecting sinus tracts which may connect with the general 
peritoneal cavity32. 
 
            In patients with suspected perforation as well as in those with 
peritonitis, subphrenic abscesses or other post surgical complicatons, there is 
a need for a contrast medium which will not produce more adhesions or 
aggravate the peritonitis should the medium leaks into the peritoneal cavity. 
In patients with postoperative complications of an ischaemic or obstructive 
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nature, it is imperative to outline rapidly the GI tract and determine whether 
immediate surgical intervention is necessary or whether there is time to 
observe the patient without endangering his life. The oral use of Barium 
sulphate in these patients usually implies a protracted procedure32. 
 
            Under certain conditions, water soluble iodine containing contrast 
media have advantages over barium sulfate because barium sulfate is used as 
a suspension and is therefore, osmotically inert, whereas water soluble 
contrast media are hyperosmolar solutions. Barium permits excellent 
radiographic detail and in the presence of normal small bowel motility, 
permits unequivocal as well as specific diagnoses. However, if there is an 
adynamic ileus present, the progress of barium is very slow. The barium 
sulfate which spills into the peritoneal cavity produces a fibrotic reaction, 
resulting in avascular adhesions which may envelop and shield bacteria in 
small abscesses from contact with blood borne antibiotics. Water soluble 
contrast media are hyperosmolar and therefore draw interstitial fluid across 
the intestinal mucosa into the lumen. The intestinal content thus increases in 
volume which stimulates the peristaltic activity. Water soluble contrast 
media thus act as saline cathartics in speeding up passage, but in the course 
are diluted38. This prevents the specific diagnoses beyond the mere statement 
of whether there is or is not a complete or partial small bowel obstruction. 
 
              Indications for the use of water soluble contrast media are 
(1) Mechanical obstruction- in very ill patients and in postoperative patients 
who have   adynamic ileus with partial small bowel obstruction. 
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(2) Demonstration of leaks from the GI tract39,40,41. 
(3) Small bowel study in the presence of large bowel obstruction- to avoid 
the danger of inspissation of barium proximal tot he large bowel obstruction. 
(4) Demonstration of stab wounds, sinuses ad fistulas. 
 
             About 100 ml of undiluted Gastrograffin are used if the patient has 
to swallow the contrast material. The objectionable taste of the contrast 
material is somewhat improved, as Gastrograffin contains a flavoring agent. 
If a nasogastric tube is in place, it is advisable to inject sodium diatrizoate 
(Hypaque) through it. This is mixed from powder to a concentration of 40%. 
In cases of perforation, the examination is monitored under fluoroscopy to 
prevent massive filling of the peritoneal cavity with hyperosmolar contrast 
medium. Sodium diatrizoate (Hypaque) is less costly and as it does not 
contain a flavoring agent, it is less likely to produce local tissue reaction 
than Gastrograffin32. 
 
               Dangers and contraindications of water soluble contrast media 
include the following: Water soluble contrast medium draw interstitial fluid 
into the intestinal lumen, thus speeding up the examination but diminishing 
demonstration  of detail because of dilution. If hypovolemia is present, oral 
administration of water soluble media may result in shock and possibly, 
death, particularly in infants, children, the aged and the very ill. All patients 
who are hypovolemic, particularly those enumerated above, should be 
carefully followed for their electrolyte status. Should an oral study with 
water soluble contrast be necessary in this type of patient, fluid and 
electrolyte replacement therapy must be instituted. Progressive dilution of 
the contrast medium as it approaches the site of obstruction, particularly in 
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the distal small bowel, further diminishes detail. Water soluble contrast 
media can be used in the study of possible esophageal perforations. It should 
be remembered that if an esophagobronchial fistula exists, serious 
complications may result from aspiration of water soluble hyperosmolar 
contrast medium. Pulmonary edema occurs, and if both lungs are affected, 
the results may be fatal42. Tracheoesophageal fistulae usually present clinical 
manifestations of cough with ingestion of liquids. This clinical symptom 
should preclude the use of water soluble contrast media. Small amounts of 
barium sulphate carefully monitored by fluoroscopy would be the approach 
of choice. For the same reasons it is not appropriate to use water soluble 
contrast media in the study of esophageal atresia with or without 
tracheoesophageal fistulas. 
 
                           According to Tirnaksiz et al, out of the 39 leaks reported 
from aqueous contrast studies that occurred of the 489 cases in a series, only 
17 developed clinical leaks. 25 patients who had normal swallow study 
developed a clinical anastomotic leak. There were therefore 22 (4.7%) false 
positive and 25 (5.4%) false negative results. The specificity was 94.7, the 
sensitivity, 40.4% and false negative error rate of 59.5%. Aspiration of the 
contrast agent was noted on fluoroscopy in 30 (6.5%) patients. Only 2 
(0.4%) patients developed aqueous contrast agent-caused aspiration 
pneumonia43.  
 
                             Radiological contrast studies remain the most accepted 
diagnostic tool for sub clinical anastomotic leaks after esophageal surgeries. 
But it is debatable if it is the ideal investigation. In the study reported by 
Page et al24 on 23 patients, who developed leaks following esophageal 
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surgery, contrast swallow showed leakage in only 14 (61%) patients, 
whereas esophagoscopy confirmed all the leaks. They concluded that 
diagnosis of anastomotic leakage after esophagectomy is difficult due to its 
variable presentation and the unreliability of contrast swallow. In another 
study by Alanezi et al25, four of 23 (17%) patients who had leaks had 
seemingly normal postoperative contrast studies. These studies indicate the 
low sensitivity of contrast studies in diagnosing sub clinical anastomotic 
leaks, thereby emphasizing the need to search for better diagnostic tools. 
 
                             
4.8  NUCLEAR MEDICINE IMAGING 
 
            Unstable atoms or nuclides which release energy to reach a stable 
state are called radionuclide or radioisotopes. Radioactivity refers to the 
rearrangement process that takes place within an excited nucleus. There are 
four types of radioactive decay which are of interest in nuclear medicine - 
alpha decay, beta decay, electron capture and isomeric transition. Most 
radionuclides used in nuclear imaging and therapy are manmade. They are 
produced by bombarding stable nuclei with neutrons or protons, which 
converts stable nuclei into excited ones which then undergo radioactive 
decay44.       
                                                                           
          The rate of decay is constant for each radionuclide. The decay 
constant is the probability of a disintegration per unit time and per atom. 
Isotope decay is usually characterized by the half life (t 1/2). The half life is 
the time required to reach one half of the amount present at an initial time t0. 
The activity of a sample of radioactive material refers to the number of 
  38
disintegrations per unit time. The activity present at any time, therefore, 
depends on the decay constant and the number of undecayed atoms present. 
One curie (Ci) was defined as 3.7 x 10^10 disintegrations per second. This 
was thought to be the number of disintegrations in  1g of radium. Since 
curies was such a large number, activities used in nuclear medicine were 
frequently given in milliecuries (mCi). The basic SI unit of activity is 
becquerel. 1  becquerel corresponds to 1 disintegration per  second44. 
 
4.8.1  Imaging equipment 
 
            Scintillation camera, which is the detector most commonly used in 
nuclear imaging, uses a  sodium iodide (NaI) crystal. When a sodium iodide 
crystal is struck by a photon of X- or gamma-rays, it scintillates or gives off 
energy as a flash of light. In a NaI crystal, an energized electron will 
fluoresce, as it relaxes to a ground state. This results in emission of visible 
blue light. The amount of light produced in a scintillation is proportional to 
the energy deposited  in the crystal by the incident photon. By measuring the 
amplitude of each flash of light, one can select photons of specific energies. 
This relationship between the energy of a gamma ray and the amount of light 
produced is critical to the production of good quality nuclear medicine 
images. 
 
          An array of electronic photomultiplier tubes (PMTs) detect the light 
produced in the NaI crystal. Each PMT generates a signal with an amplitude 
proportional to the amount of light which is thus a measure of the energy of 
the incident photon. The actual distribution of radioactivity in the body, as 
seen by the crystal is ultimately determined by a collimator placed in front of  
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                                           Fig 4.3  Gamma camera 
the crystal. The collimator's function is similar to that of a lens of a camera 
focusing light rays onto a film. Photons which arrive at an angle to the 
crystal will not penetrate the collimator. Spatial resolution (which is a 
measure of the precision of locating the source of gamma rays) is best if the 
collimator is close to the source. Collimators are usually made of lead and its 
performance is determined by the number of channels and holes, the hole 
diameter, the length of each channel and the septal thickness. Collimators for 
low isotopes can be very efficient because the septa are very thin and more 
holes with smaller diameter can be used. 
 
        The speed at which a scintillating camera can count incident photons is 
determined by the electronics of the camera as well as the properties of the 
NaI crystal. The ‘dead time’ of a detector is that time during which the 
system cannot respond to an incident photon. It is also referred to as the 
resolving time and the time that must separate two events for the system to 
recognize them. Most cameras today have 'dead times' in the range of 1.5 - 
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2.0 microseconds, giving maximum count rates of 50,000 - 60,000 counts 
per second44. 
 
4.8.2  Imaging methods  
 
                 A wide variety of diagnostic imaging methods are used in nuclear 
imaging- static, whole body, dynamic, SPECT and positron emission 
tomography (PET). 
  
                Static imaging is the acquisition of a single image of a particular 
structure. This image can be thought of as a snapshot of the 
radiopharmaceutical distribution within a part of the body. Static images are 
obtained in various orientations around a particular structure to demonstrate 
all aspects of that structure. Low radiopharmaceutical activity levels are used 
to minimize radiation exposure to the patients. Because of these low activity 
levels, images must be acquired for a preset time or a minimum number of 
counts or radioactive emissions. This time frame may vary from a few 
seconds to several minutes to acquire 100,000 to more than 1 million counts. 
Generally, it takes 30 seconds to 5 minutes to obtain a sufficient number of 
counts to produce a satisfactory image. 
  
          Whole body imaging uses a specially designed moving detector 
system to produce an image of the entire body or large body section. In this 
type of imaging, the gamma camera collects data as it passes over the body. 
These are used primarily for whole body scans, whole body tumor or abscess 
imaging and other clinical and research applications. 
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        Dynamic images display the distribution of a particular 
radiopharmaceutical over a specific time period. A dynamic or 'flow' study 
of a particular structure is generally used to evaluate blood perfusion to the 
tissue. This can be thought of sequential or time lapse images. Images may 
be acquired and displayed in time sequences as short as one-tenth of a 
second to longer than 10 minutes per image. Dynamic imaging is commonly 
used for first pass cardiac studies, hepatobiliary studies and gastric emptying 
studies. 
 
          SPECT produces images similar to those obtained by CT or MRI in 
that a computer creates thin slices through a particular organ. This imaging 
technique has proved very beneficial  for delineating small lesions within 
tissues and can be used on virtually any structure or organ. 
 
          PET imaging uses positron emissions from particular radionuclides to 
produce detailed functional images within the body. PET is unique in that its 
images are of blood flow or metabolic processes at the cellular level rather 
than the conventional anatomic images produced by X-ray, CT, MRI or even 
SPECT44. 
 
4.8.3  Radiopharmaceuticals  
 
            A radiopharmaceutical is a radioactive substance, which exhibits 
spontaneous disintegration of unstable nuclei with the emission of nuclear 
particles or photons. Radiopharmaceuticals can be subdivided into 
therapeutic and diagnostic agents. Therapeutic agents are used to deliver 
particulate radiation for the destruction of tissues or cells. Common 
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examples are P-32 and I-131. Diagnostic radiopharmaceuticals are gamma 
emitting or positron emitting radionuclides used for imaging a specific organ 
system or for evaluation of a physiological process. Use in humans is 
regulated by Governmental agencies which impose strict guidelines for their 
safe and effective use in therapy and diagnosis. 
 
           The radionuclide determines the radiation dose to the patient, as well 
as the imaging properties needed by the detection system. Large numbers of 
emitted photons are needed for accurate temporal and spatial localisation of 
a radiopharmaceutical. Short lived isotopes which can be given in large 
doses to yield high count rates over a relatively short period of time are 
desirable so that the count rates are high, yet with a total body radiation. 
While it is desirable for an isotope to have the shortest practical half life, this 
must be compatible with the half time of the physiological process being 
studied. Any isotope which decays away before the completion of the 
biological process under study would obviously be of little clinical use. The 
energy of emitted gamma ray is also important  for detection by a 
scintillating cameras. Gamma rays from 75 - 300 keV are most suitable for 
imaging with conventional scintillating cameras44. 
 
           Historically, iodine has played an important role in nuclear imaging. 
The major disadvantage of iodine is that none of its isotopes are ideally 
suited for routine nuclear imaging. So they have been replaced by Tc-99m or 
In-111. Tc-99 and In-111 can be subdivided into metal-essential and metal-
tagged agents. Metal tagged agents use radio nuclides to trace the 
distribution pattern of the unlabelled material. The attachment of the radio 
nuclides to these compounds does not alter the normal distribution of these 
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compounds. Metal-essential agents, however, require the metal to be 
complexed by the ligand in order to achieve the desired tracer localization. 
 
Metal tagged agents: 
  Proteins:       Monoclonal antibodies  
                       Plasma proteins  
                       Human serum albumin 
  Colloids:      Sulfur colloid 
                      Microaggregated albumin 
                      Macroaggregated albumin 
   Cells:          RBCs 
                      WBCs 
 
Metal essential agents : 
   Brain perfusion:   Hexamethyl-propyleneamine 
                                    oxime 
   Myocardial:          Isonitriles 
   Renal:                   DTPA 
                                Mercaptoacetyl triglycine 
                                Glucoheptonate 
                                Dimercapto succinic acid 
   Hepatobiliary:      Imino diacetates 
                                Pyridoxylidiene glutamate 
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4.8.4  Tc-99 radiopharmaceutical agents 
 
                           Tc-99 is utilized for the vast majority of all nuclear imaging 
and is obtained as a daughter product of molybdenum-99. Mo-99 has a 67-
hour half life and decays 86% of time to the metastable state of Tc-99m and 
14% of the time directly to Tc-99. Tc-99m has a 6.02 hour half life and 
decays to Tc-99 with the emission of a 140-keV gamma emission and lack 
of particulate radiation.  
 
                    The problems associated with Tc-99m sulfur colloid are : 
(1)High quantities of carrier Tc-99 may increase the concentration of free 
pertechnetate in a reconstituted kit. (2)An improper pH during preparation 
may degrade Tc-99m sulfocolloid yielding free pertechnetate. (3)Aluminium 
may form a precipitate with Tc-99m sulfocolloid with the resulting particles 
lodging in the pulmonary capillaries causing lung visualization. 
(4)Sulphocolloid particle size is dependant on heating time. The size may 
increase if the kit is heated longer than the recommended time with potential 
lung visualization. If heated for less time particle size decreases with 
alterations in the liver to spleen ratios. (5)Particle size of Tc-99m 
sulfocolloid may change after reconstitution due to agglomeration of 
particles in vivo44. 
                                     Tc-99m is safe with regard to radiation hazard 
especially because of its short half life.  
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4.8.5  Esophageal transit scintigraphy 
 
             The movement of a swallowed bolus through the esophagus is 
defined as esophageal transit whereas emptying from the esophagus of 
material which has been refluxed is defined as clearance. Radionuclide scans 
are useful in screening patients with suspected esophageal motility disorders 
as well as for monitoring response to treatment.  
 
            The single swallow technique uses multiple regions of interest to 
characterize the progression of the esophageal bolus following a single 
supine swallow of 250 mCi of Tc-99m sulphur colloid in 10 ml of water. 
Images are recorded on the gamma computer system at a 0.4 second/ frame 
rate for upto 60 seconds. In multiple swallow tests by Tolin, 150-300 mCi of 
Tc-99m sulphur colloid in 15 ml of water is ingested as a single swallow in 
the supine position and followed by dry swallows at 15 sec intervals up to 10 
min. These esophageal transit studies have been used in the evaluation of 
esophageal disorders like achalasia cardia, diffuse esophageal spasm, 
nutcracker esophagus, oculopharyngeal muscular dystrophy, reflux 
esophagitis, gastroesophageal reflux, Barrett's esophagus, hiatal hernias, 
pharyngoesophageal diverticulum, and malignant tumors of the esophagus 
are included. These scans have not been reported to be used for the purpose 
of detecting anastomotic leaks in postoperative patients44. 
 
 
 
 
 
  46
 
4.9 RADIATION PROTECTION 
 
          After exposure to high doses of radiation, a number of early responses 
may appear. A whole-body radiation dose in excess of 200 rad (2mGy) can 
result in death within weeks. Partial body irradiation to any organ or tissue 
can cause atrophy and dysfunction. A whole body radiation of as low as 25 
rad (250 mGy), may produce measurable hematological depression. 
 
        These early responses result from high doses of radiation rarely 
experienced in diagnostic radiology. Such effects are called deterministic. 
The principle concern today is for late effects of radiation exposure. These 
effects are called stochastic. The incidence of response is dose related and 
there is no dose threshold. Such effects of low dose radiation exposures may 
not occur for years and they fall into genetic or somatic categories. 
 
4.9.1 Radiation units 
 
              When an X-ray tube is energized, X-rays are emitted in a collimated 
beam and this beam ionizes the air through which it passes. This effect is 
called exposure. The unit of exposure is roentgen(R) (conventional) and 
C/kg or Gy (SI unit). 1 R = 10 mGy. When the radiation exposure occurs, 
the resulting ionization deposit is in the air or in the patient who has been 
exposed to. This is the absorbed dose and it is measured in rad. One rad is 
equivalent to depositing 100 erg of energy in each gram of tissue. The SI 
unit of absorbed dose is the gray and 1 Gy = 100 rad = 1 J/kg. If the 
irradiated object is a radiation worker or the public, then the radiation dose 
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results in a dose equivalent. The dose equivalent is measured in rem 
(radiation equivalent man) and 1 rem = 100 erg/g. The SI unit of dose 
equivalent is the sievert (Sv) and 1 Sv = 1 J/kg. When a medical physicist 
evaluates the performance of an x-ray imaging system, the radiation 
intensity is expressed in mR/milliampere-seconds at a given kilovolt45. 
 
4.9.2 Medical radiation dose and exposure 
 
             Various factors like the type of equipment, technique employed, 
model of machine, whether radiographic or fluoroscopy and the X-ray 
intensity, all put together determine the radiation dose to the patient as well 
as the radiographer. Patient dose during fluoroscopy is difficult to estimate 
because the X-ray beam is modulated and moves during the examination. 
Fluoroscopes have X-ray intensity limited by regulation to 10 R/min at the 
tabletop. Experience has shown that, when operated at approximately 
90kVp, most fluoroscopes produce tabletop exposure of approximately 4 
R/min. Radiographic x-ray intensity varies directly with the mAs, with the 
square kVp and inversely as the square of the distance from the source. A 
good approximation of X-ray intensity during radiography is 5 mR/mAs at 
80 cm source-to-skin distance(SSD)45. 
 
                    The dose received by patients during diagnostic radiological 
examination is usually expressed in one of the 3 ways: entrance skin 
exposure (ESE), organ dose or fetal dose. Organ dose and fetal dose cannot 
be measured but has to be calculated.  The ESE of the patient during any 
radiographic examination can be measured directly or estimated by various 
techniques. Too low a radiation exposure is as hazardous as excessive 
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radiation exposure because an inadequate image is produced making 
diagnosis less precise and needing repeat radiographic examinations. The 
range of acceptable ESEs for selected radiographic examinations in mR are 
as follows:                                                    
                                                                                                                                                     
        Chest(PA)                                                                                   10 to 25  
        Skull (lat)                                      105 to 240 
    Abdomen (AP)                              375 to 700 
    Retrograde pyelogram                          475  to 830 
   Cervical spine (AP)                       35 to 165 
    Thoracic spine(AP)                       295 to 485 
     Extremity                                      10 to 330 
   Dental (bite-wing & peri-apical)    230 to 425 
    
                Damilakis J et al estimated the average patient dose and risks 
associated with upper gastrointestinal contrast studies from data collected 
from 25 studies done on infants. The cases were divided into 2 groups – 
Group 1 including 12 infants ranging from 0.5 to 5.9 months and Group 2 
including 13 infants aging from 6 months to 15 months. The mean total 
fluoroscopy time was 1.26 and 1.62 min for groups 1 and 2, respectively. 
The average effective dose was 1.6 mSv for group 1 and 1.9 mSv for group 
2. The risk of cancer attributable to the radiation exposure associated with a 
typical UGIC study was found to be up to 3 per 10 000 infants undergoing 
an UGIC examination. The mean radiation dose absorbed by the hands of 
comforters was 47 microGy. In conclusion, radiation dose values associated 
with UGIC examinations carried out to infants are not low and should be 
minimized as much as possible46. 
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                        In yet another study done by Delichas MG et al on 41 barium 
meal and 42 barium enemas, mean total DAP values were found to be 25 +/- 
11 Gy cm2 for BM and 60 +/- 35 Gy cm2 for BE examinations, whereas the 
estimated mean values of effective dose were 8.6 +/- 4.0 and 24 +/- 16 mSv 
respectively. DAP to effective dose conversion coefficients were estimated 
to be 0.34 mSv per Gy cm2 for BM and 0.41 mSv per Gy cm2 for BE47.  
Other studies also report the increased radiation hazards involved in upper 
GI contrast studies48,49.   
                 
4.9.3 Radiation safety in nuclear medicine 
 
             The radiation protection measures in nuclear medicine are different 
from the general radiation safety measures used for diagnostic radiography. 
The radio nuclides employed in nuclear medicine are in liquid, solid or 
gaseous form. Because of the nature of radioactive decay, these radio 
nuclides continue to emit radiation after administration. Therefore, special 
precautions are required. 
 
          In general, the quantities of radioactive tracers used in nuclear 
medicine present no significant hazard. Nonetheless, care must be taken to 
reduce unnecessary exposure. The handling and administering of diagnostic 
doses to patients warrants the use of gloves and a lead syringe shield, 
especially effective for reduction of exposure to hands and fingers during 
patient injection. But Tc-99m, the most commonly used radionuclide, due to 
tits short half life has almost negligible radiation hazard when administered 
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at low dose. Only at high doses does it become hazardous but that too for a 
short period of time. 
 
                 The radiation safety in Technetium agents have been mainly 
studied in breast sentinel node biopsies. According to a study done by 
Strattmann et al, 21 patients were injected with 0.7 to 1.1 mCi of technetium 
sulphur colloid1.5 to 3 hours before a sentinel lymph node biopsy. They 
concluded that radiation exposure to operating room personnel, pathologists, 
and operative equipment during a breast sentinel node biopsy using Tc99m 
is minimal. A primary surgeon can perform 2,190 hours, a scrub nurse 
33,333 hours, and a pathologist 14,705 hours of procedural work before 
surpassing Occupational Safety and Health Administration limits. Operative 
instruments, pathology slides, and cryostat machines do not require special 
handling. All lumpectomy specimens should be stored for decontamination 
until the dose rate equals background levels50. 
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  5. Methodology   
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             This study aimed at exploring the diagnostic feasibility and efficacy 
of nuclear images in the detection of postoperative sub clinical anastomotic 
leak. 
5.1  Patients 
              Cases for the study were selected according to a set of inclusion and 
exclusion criteria. They were as follows: 
    5.1.1  Inclusion criteria: 
- All patients undergoing the following operations, irrespective of 
age or sex, were included for the study. 
               # Esophagectomy with reconstruction – Transhiatal, transthoracic  
                  ( Ivor- Lewis, McKeown’s), en bloc  esophagectomy. 
               # Substernal colon bypass with or without esophageal resection 
               # Total gastrectomy 
               # Proximal gastrectomy 
     5.1.2  Exclusion criteria: 
        1. All patients who are clinically unstable and may not be able to 
            tolerate both the studies as according to the surgeon’s judgment.  
        2. Patients with clinically obvious leaks. 
        3. Patients in whom both the studies could not done to completion. 
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5.2  Methods       
               
                  A pilot study was done on 5 patients to explore the feasibility of 
the study and also to standardize the vehicle, dose, volume and timing of the 
Technetium studies. 2 patients underwent esophagectomy and 3 underwent 
total gastrectomy. Technetium sulphocolloid and Technetium-DTPA were 
tried as radionuclide agents. It was decided to use Technetium sulphocolloid 
scans for reasons of superior quality. Milk and sterile water were tried as 
vehicles. Since sterile water was more physiological and safer for a patient 
in the postoperative period, it was decided to use plain water as the vehicle 
for radionuclide. The dose of radionuclide was standardized at 5 mCi per 
patient with a volume of vehicle ranging from 30-100 ml.  
 
                 Since there were no similar studies recorded in literature, it was 
decided to have a sample size of 40 based on an estimate of the number of 
patients that can be studied in the time period of the study.                      
After the detailed research plan was laid down, approval was obtained from 
the Department of Upper Gastrointestinal Surgery unit and the fluid research 
committee. The study extended for a period of 18 months from March, 2005 
to August, 2006  
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                        All patients who underwent the operations listed in the 
inclusion criteria were selected for the study after obtaining informed 
consent. Selected preoperative, intraoperative and postoperative data as 
mentioned in the proforma were collected  for each patient. Patients who 
satisfied the exclusion criteria during the course of the study were taken off 
the study.   
                        Technetium sulphocolloid scans were undertaken on the 8th 
postoperative day and barium meal studies  on the 9th postoperative day. The 
patients were interviewed after the procedures and a discomfort analogue 
score was obtained from each patient. The score was a subjective score 
measured on an ordinal scale and displayed the level of discomfort 
experienced by the patient during the study. The highest possible score was 
10 and it expressed the maximum discomfort the patient could imagine. The 
lowest score was 0 which described the state in which consumption of the 
study solution was comparable to what the patient considered as effortless as 
drinking potable water. The scans were reported independently by the 
nuclear medicine physician and the radiologist respectively. Technetium 
scan reports were not used for decision on further management. All 
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decisions regarding further management of patient was done on the basis of 
report of the barium study. 
                       
  5.2.1 Technetium sulphocolloid studies 
                     Technetium sulphocolloid scans were planned for the after 
noon of the 8th postoperative day. Just prior to the procedure, patient was 
given a test feed of about 15 ml of plain water. If the patient tolerated the 
test feed, he was taken for the scan. 
 
                     Sterile water was used as the vehicle of radioactive material. 
30-100 ml of sterile water with 5 mCi of Technetium was prepared and the 
patient was instructed to drink the liquid while images were taken with 
gamma cameras. Initially, dynamic images were taken as 5-second frames 
for 5 min. Patient took the next swallow in a supine position and 5-second 
frames were taken for 5 min. Similar static images are taken for ½ hour in 
antero-posterior  and lateral  views. A delayed study was done if the nuclear 
medicine physician wanted further clarifications on the previous images.. 
Images were stored and analyzed with the help of computers. The final 
report was reported by the Head of the Nuclear Medicine Department. The 
report gave details of the appearance of the images as well as about the 
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presence or absence of anastomotic leaks. This report was not used for 
further decisions on management but only for study purposes. 
 
5.2.2 Radiological contrast study: 
           Contrast esophagography was planned for the morning of the 9th 
postoperative day. Thin barium was used as the contrast agent. No 
procedural restrictions were placed. The images were analyzed and reported 
by the radiologist as routinely done. Further decisions on management were 
based on the report. 
 
5.3 Data analysis 
                Data obtained from the study was tabulated and analyzed with the 
help of the Department of Community Medicine and Biostatistics and the 
results are presented in the next section. 
 
 
                                                 
 
 
 
 
 
 
  57
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 6.Data Analysis 
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                                  6.1 PATIENT PROFILE 
 
 
6.1.1 Number of cases enrolled 
 
                             51 cases were enrolled into the study of which 13 cases 
were excluded from the study due to the various exclusion criteria. The 
reasons for exclusion form the study were as follows. 
 
1.    Patients who were clinically unstable during the time of the tests – 4  
       patients.       
2.    Patients who developed clinically detectable leaks prior to the imaging –  
       5 patients.        
3.    Patients who could not complete either one of the study due to patient 
       related factors -1 patient (Barium induced vomiting). 
4.   Patients who could not complete either one of the study due to technical  
 reasons- 2 patients. 
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6.1.2 Age – sex distribution of patients 
 
 
age-sex distribution of cases
0
1
2
3
4
5
6
7
20-29 30-39 40-49 50-59 >60
age groups
nu
m
be
rs male
female
 
          Figure 6.1: Age-sex distribution of patients in the study 
 
                                        Of the 38 cases were studied, there were 20 
males and 18 females. The age-sex distribution of the studied population 
has been depicted. The above bar diagram shows that female cases were 
predominant in the younger age group and as age increases male cases 
predominate. This is probably due to the higher incidence of benign 
corrosive acid strictures in the female younger age group.  
 
 
  60
6.1.3 Clinical presentation profile in patients  
             The common symptoms with which the patients presented with 
are depicted in the picture below. 
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              Figure 6.2: Common presenting complaints of patients in the study 
 
                            The most common symptom among the 38 cases studied 
was loss of weight. Other important symptoms were loss of appetite, 
epigastric pain, dysphagia and vomiting. Some of the minor symptoms 
that were included under the heading of ‘others’ were hematemesis, 
odynophagia, generalized weakness, early satiety and regurgitation. 
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6.1.4 Duration of symptoms  
               The duration of the first symptom was tabulated and depicted in 
the bar diagram: 
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Figure 6.3: Duration of the first symptom (months) 
                
                  The duration of the first symptom ranged from 1 month to 48 
months. The mean was 8.79 months. In 20 of the 38 cases, the duration of 
the first symptom was in the range of 3 to 6 months. 
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6.1.5 Personal and past history 
 
                 8 patients (21.1%) had history of smoking. 4 patients (10.5%) 
were known diabetics at the time of study while 3 patients (7.5%) were 
known hypertensives. The other co-morbidities that were also associated 
in the patients in the study were tuberculosis(1), thyroid disorders(2), 
dyslipidemia(3), situs inversus(1) and chronic renal failure(1).  
 
                Only one out of the 38 patients had a history of previous 
radiotherapy while 4 patients had history of previous chemotherapy. 9 
patients of the 38 cases had history of previous operation. 4 of these 9 
patients had esophagogastric operations while another 4 patients had 
other GI operations. 
 
               Analysis done to identify any associations between history of 
smoking, previous radiotherapy and chemotherapy did not reveal any 
significant associations. 
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Other variables 
 
Variable Mean Standard   
deviation
Significant 
association  
  with leak 
BMI 20.69 1.4 Nil 
Hemoglobin 10.6 gm% 2.2 Nil 
S. albumin 3.8 mg% 0.58 Nil 
             Table 6.1 
              
                 The height and weight of all the patients were tabulated and 
the body mass index was calculated according to the formula: 
                   BMI = Weight (kg) / Height2 (cm)        
             
               The normal BMI of the general population was between 22 and 
25. BMI of the study patients ranged from 15.6 to 26.0 with a mean of 
20.69 and a mode of 21.7.  42% of patients had a BMI between 18.0 and 
21.9 while 74.5% of patients had a low BMI. This was in agreement to 
the fact that loss of weight was the predominant presenting symptom in a 
majority of the study patients. 
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                 The blood investigations that were analyzed were hemoglobin 
and Serum albumin. Hb values were in the range of 5.4 to 15.6 with a 
mean of 10.6 gm% (SD- 2.2). The mean serum albumin value was 3.8 
mg% ( SD-0.58) while the values ranged from 2.3 to 4.9. Any association 
between these variables to the development of anastomotic leaks 
according to barium study was tested by the chi square test and found to 
be not significant. 
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                      6.2 PROFILE OF MANAGEMENT 
 
6.2.1 Types of Surgery done 
 
Surgery done Number 
Ivor Lewis esophagectomy      2 
McKeown’s esophagectomy      2 
Total gastrectomy     31 
Substernal colon bypass      2 
Distal esophagectomy + proximal esophagectomy      1 
Table 6.2:  Types of surgery done for study patients 
 
                 The majority of cases in the study underwent total 
gastrectomy. This is because the number of esophageal resections was 
relatively low and some of the cases who underwent esophagectomy fell 
into the exclusion criteria due to early clinical leaks  
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6.2.2 Histopathology 
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Figure 6.4: Profile of final biopsy report of patients 
                              
                 Since majority of the cases were carcinoma stomach, the most 
common biopsy reports were moderately or poorly differentiated 
adenocarcinoma. Squamous cell carcinoma was reported in esophageal 
lesions. Other rare lesions like schwannoma, leiomyoma, GIST, lymphoma 
or corrosive strictures were also included. 
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6.2.3 Intraoperative data  
 
              Duration of surgery was clearly seen to be dependant upon the type 
of operation done. Mean duration of esophagectomy was 7 hours while that  
for total gastrectomy was 4 ½ hours. 
 
               Stapled anastomosis was done in 13 out of the 38 cases (34.2%) 
while the rest were handsewn. Of the 13 stapled anastomosis, one patient 
developed leak while of the remaining 25 cases who underwent a hand sewn 
anastomosis, 5 had anastomotic leaks as according to barium contrast 
studies. However, a chi square test did not show any significance for 
association. 
 
                Intraoperative hypoxia was recorded in only one case 
(McKeown’s esophagectomy). Intraoperative hypotension occurred in 5 
cases. Mean blood loss recorded during surgery was 492 ml. 19 of the 38 
cases did not require blood transfusion. 
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6.2.4 Postoperative data 
                The number of ventilator days postoperatively ranged from 0 to 11 
days. 29 cases did not require postoperative ventilation while 5 patients 
required 2 or more days of postoperative ventilation. Similarly, 26 cases 
required did not require postoperative monitoring in Surgical ICU while 
remaining cases required 1 to 15 days in ICU. 4 out of 38 cases developed 
postoperative ARDS. Margins were free only in 20 of the 38 cases (52%).7 
out of the 38 cases did not develop post-operative fever. The number of 
episodes of spikes of fever ranged from 1 to 10 with a mean value of 2.26 
spikes(SD- 1.76),for the first ten days post-operatively. 
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6.3 COMPARISON OF TECHNETIUM AND BARIUM  
  IMAGING IN DETECTING SUBCLINICAL 
  ANASTOMOTIC LEAKS  
 
 
6.3.1 Leak in Technetium sulphocolloid scan 
                 Technetium sulphocolloid scans detected 10 leaks out of the 38 
study cases. Of these, 9 leaks were reported as blind fistulous tracks from the 
anastomotic site with pooling of radioactive contrast. One scan was reported 
as consistent pooling of radioactive contrast at the anastomotic site depicting 
a contained leak. Of the 10 cases that were shown to be leak positive by 
technetium, 5 were also picked up by barium while the remaining 5 were 
missed by barium.  
 
6.3.2 Leak in Barium contrast studies 
            Barium contrast studies detected 6 leaks out of the 38 cases studied. 
Of the 6 cases, one leak was detected exclusively by barium contrast studies 
while all other 5 leaks were detected by both the studies. 
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6.3.3 Technetium sulphocolloid esophageal scintigram –  
         normal 
 
 
 Figure 6.5 Normal technetium sulphocolloid scintigram (dynamic images) 
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Figure 6.6 Normal technetium sulphocolloid scintigram (static images)  
 
 
  72
6.3.4 Technetium sulphocolloid esophageal scintigraphy –  
         anastomotic leak  
 
 
Figure 6.7 Technetium sulphocolloid esophageal scintigraphy-         
anastomotic leak (dynamic images) 
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Figure 6.8 Technetium sulphocolloid esophageal scintigraphy-         
anastomotic leak (static images) 
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6.3.5 Results         
 Barium study Total 
  
   Leak   
present No leak   
 
  Technetium 
      
  
  Leak 
present 
5 5 10 
        
  Scintigraphy 
 
 
 No leak 
1 27 28 
 
                Total 6 32 38 
     Table 6.3 Barium contrast studies Vs Technetium scinitigraphy 
 
                        Data analysis of the results of the above imaging studies was 
done with the kappa statistic. Kappa expresses the extent to which the 
observed agreement exceeds that which should be expected by chance alone. 
Landis and Koch suggested that a kappa greater than 0.75 represent 
excellent agreement beyond chance, a kappa of 0.4 to 0.7 represents 
intermediate to good agreement and below 0.4 represents poor agreement51. 
 
                        Kappa value was calculated to be 0.533 with a standard error 
of 0.162. This value according to Landis and Koch is of good agreement 
between the two studies. 
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6.4 COMPARISON OF DISCOMFORT ANALOGUE 
      SCORES 
           
Comparison of Discomfort analogue scores 
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Figure 6.9                     
 
                     The above graph shows a clear separation of scores towards 0 
to 5 for Technetium scans and towards 5 to 10 for barium scans. The mean 
value for discomfort during administration of the technetium study was 3.95 
and the mean value for discomfort during administration of the contrast 
study was 5.84 .The significance of this difference was tested using a paired 
samples test, for which a ‘t’ value of -5.029 (  p<0.001 )  was obtained and 
the result was taken as significant. 
  76
 
                           
 
 
 
 
 
 
 
     
      7.Discussion 
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               Anastomotic leaks are one of the commonest complications after 
esophageal operations. The most effective way of managing anastomotic 
leaks is to detect it at a sub clinical level. This allows the treating surgeon to 
alter his management plans so as to hasten closure of the leak and prevent 
progression into a clinical leak. Studies have already demonstrated that 
barium contrast studies, which is the current investigation of choice, is not 
the ideal one. 
 
                    There is as yet no gold standard for the  detection of sub clinical 
anastomotic leaks. Some studies have used clinical leaks as the gold 
standard while some have used esophagoscopy. It is assumed that all 
subclinical leaks need not progress into a clinical leak and therefore 
progression into a clinical leak is not a suitable gold standard for evaluation 
of a test to diagnose subclinical leaks. No studies are available in literature 
about the sensitivity of esophagoscopy but scopy in a postoperative setting 
may do more harm than good to the anastomosis. Therefore, one of the 
limitation of the study was the lack of a proper gold standard to calculate the 
validity criterion. 
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                      Barium studies, even though far from being ideal, is the best 
investigation currently available. Since there was no proper gold standard, it 
was decided to assess the agreement in the reporting of the Technetium 
nuclear images and the barium contrast images. In this study, this agreement 
was  assessed with a Kappa statistical analysis. A kappa value of 0.533 with 
a standard error of 0.162 shows a good agreement between the two studies in 
terms of detecting sub clinical anastomotic leaks. The analysis also shows 
that technetium scans detected 5 anastomotic leaks that were not detected by 
barium scans while barium scans detected only one case over technetium 
scans. This observation though statistically not significant, can be explained 
either as a higher sensitivity rate of technetium scans over barium scans or as 
a higher false positivity rate of technetium over barium scans. Further 
studies aiming at estimating sensitivity and specificity of this diagnostic test 
need to be done. 
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Advantages of Technetium scans 
 
                  This study shows a good agreement between the two 
investigations. Technetium scans can be considered superior to barium if 
there are clear advantages of technetium over the same variables in barium. 
                  The advantages of technetium as seen during this study were as 
follows: 
1. Technetium sulphocolloid scans used plain water as its vehicle when 
compared to the more viscous barium. Plain water was more 
physiological in the GI tract and thereby had the least effect on the 
anastomotic site. 
2. The radiation hazard posed by technetium is very minimal when 
compared with contrast imaging. This fact is elaborated in the 
literature review. 
3. The cost of a technetium scan in our institution was only Rs. 700 
when compared to Rs. 1600 for a barium scan.  
4. Technetium has a half life of 6 hours after which it is excreted from 
the body through the kidney. Barium, on the other hand is a 
suspension and is excreted in stools because of which it is dependant 
on proper bowel function. For the same reason, previously 
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administered barium can interfere with repeat barium scans 
especially if there was a leak. 
5. Technetium that leaks into the abdomen or thorax is not known to 
cause complications like peritonitis unlike barium. 
6. The discomfort analogue score is significantly higher following 
barium studies as confirmed by relevant statistical tests (p 
value<0.001). Moreover, one of the cases who were excluded from 
the study did not tolerate barium.  
          
      Disadvantages of Technetium scan  
1. Routine use of technetium scan can only be considered in a setting 
where infrastructure for nuclear scan imaging exists. 
2. Technetium scans have poor delineation of the GI tract in terms of 
luminal defects as compared to barium which has excellent 
visualization of the bowel lumen. 
3. Skeletal visualization is not possible with technetium scans because 
of which exact level of lesion may not be identified. 
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Association of patient related factors to anastomotic leak 
 
                         Various studies have described the association of patient 
related factors in the development of anastomotic leaks. Some of the patient 
related associations that have been already established are presence of 
comorbidities, previous history of radiotherapy and chemotherapy and 
nutritional status as according to the preoperative albumin level. The 
occurrence of intraoperative hypoxia and hypotension, duration of 
anaesthesia, total blood loss, postoperative ventilator days and development 
of ARDS and sepsis have also been known to have an association with 
development of anastomotic leaks. 
 
                         In this study, an attempt was made to determine the 
association of these factors on the development of anastomotic leaks. Leaks 
detected by barium studies were used for these associations. Of all the 
associations studied, only the number of postoperative ventilator days 
showed some association with development of anastomotic leak but it was 
not statistically significant. 
 
                       The fact that sub clinical anastomotic leak and not 
anastomotic leak was the end point of the study would probably be one of 
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the reasons for the lack of association of these factors. Moreover, the 
number of leaks as according to barium studies was only 6 which is a very 
small number to make any conclusions from. The sample size was also too 
less for determining associations.  
 
 
 
                                         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  83
                8. Conclusion 
 
 
1. Technetium sulphocolloid esophageal scintigraphy have a good  
agreement with barium contrast studies in detecting sub clinical 
anastomotic leaks.  
2. The sensitivity of technetium scans could not be assessed due to lack of 
a proper gold standard.  
3. Technetium scintigraphy was found to have detected more sub clinical 
anastomotic leaks than barium. 
4. Technetium sulphocolloid scans are more economical than barium 
contrast studies.  
5. Technetium sulphocolloid imaging does not cause any of the 
complications of barium such as barium peritonitis or barium 
inspissation.  
6. The amount of radiation exposure to the patient as well as his/her 
attendants is negligible.  
7. Technetium is excreted from the body rapidly and so repeat scans are 
not confounded by the old technetium.  
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8. Technetium sulphocolloid scans use sterile water as its vehicle because 
of which it is more physiological and is easier for the patients.  
9. Swallowing of technetium sulphocolloid produced statistically 
significant lesser discomfort to the patient as compared to barium as was 
proved by the comparison of the discomfort analogue score. 
10. Further studies with larger sample sizes are needed for evaluating the 
validity criterion of Technetium sulphocolloid esophageal scintigraphy. 
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                  Limitations 
 
 
 
                            Like any other study, this had certain limitations. The 
sample size was small. This was mainly due to the short duration of the 
study and due to limitation in the number of cases that were available for the 
study. A larger sample size would have probably helped in conclusively 
proving the validity of the study. 
                         Literature shows a higher rate of leaks associated with 
esophagectomy than is seen in this study. In this study, there were only a 
small number of esophagectomies that could be studied due to a good 
proportion that became excluded from the study. 
                        The lack of a proper gold standard was one of the major 
limitations of this study.  Barium, being the routine imaging was considered 
the gold standard but the sensitivity and specificity of barium is highly 
debatable. A larger sample size or a more ideal gold standard would have 
helped in analyzing the sensitivity and specificity of Technetium 
sulphocolloid scans  
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                                    11.1 PROFORMA 
                                          
Name of patient:                                         Age:       Sex:     Hospital No.:              
 
Clinical details 
Symptoms with duration: 
         
Treatment history: 
        Radiotherapy 
       Chemotherapy 
        Previous surgery         
History of  Smoking:         
Comorbidities: Diabetes:              Others:                          
Wt:        Ht:         BMI:                  
 
Investigations         
Hb                            S. albumin:               Level of lesion: 
Biopsy:          
Diagnosis: 
 
Intraoperative period 
Surgery done: 
Duration of surgery:                  Duration of anaesthesia: 
Components of anastomosis: Esophago-esophageal/ Esophagogastric/   
Esophagojejunal/ Esophagocolic. 
Use of staples for anastomosis: 
Level of anastomosis: Upper/ Middle/ Lower third of esophagus 
Prolonged hypoxia:                           Prolonged hypotension:              
Total blood loss: 
Transfusion requirement: 
 
Postoperative period 
No. of days on ventilator:                     No. of days in SICU:  
Occurrence of ARDS: 
Number of fever spikes in first 10 postoperative period:    
Margin positivity in pathology specimen(in cases of malignancy): 
 
Radioscintigraphy study   
Discomfort analogue score:            Presence of anastomotic leak: 
 
Radiological contrast studies 
Discomfort analogue score:            Presence of anastomotic leak: 
 
Clinical follow up 
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                                       11.2  INFORMED CONSENT 
 
                 I have been informed about a study being conductedin CMC hospital on 
patients who have undergone surgeries involving esophageal anastomosis. I have 
been informed about the components of the study and the pros and cons of it . I 
understand that my participation is completely voluntary and that I may choose to 
withdraw from this study at any time. I also understand that my refusal to take part in 
the study will not affect my treatment in any manner.  
                Having read and understood the consent form, I hereby agree to participate 
in the study. 
 
Date: 
                                                                                                 Signature of patient 
 
                                                                                                  
                                                                                                 Name of patient 
 
 
 
                 Signature if principal investigator: 
        
                                                                                (Dr. Sujith Varghese Thomas) 
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                        11.4 MASTER DATA – VARIABLE DESCRIPTION 
 
 
 
Age :           1  -     20 to 29 years                           Sex:  1  -  Male 
2 -  30 to 39 years                                    2  -  Female 
3 -  40 to 49 years 
4 -  50 to 59 years 
5 -  > 60 years 
 
Symptoms :  Symptoms a to e represents a list of symptoms that patient presented with. There is no 
relationship to the timing or importance of symptoms. 
Durat : Duration of the first significant symptom in months 
RT : History of previous radiotherapy       0 – No   1 – Yes  
Chem : History of previous chemotherapy      0 – No   1 – Yes 
PrevSx : History of previous surgery     
1 -  Esophagogastric surgery 
2 -  Other GI surgery 
3 -  Thoracic surgery 
4 -  Others 
Smok : Known cigarette smoker       0  -  No     1  -  Yes 
DM : Known diabetic        0  -  No     1  - Yes 
HT : Known hypertensive        0  -  No    1  -  Yes 
Others :  Other comorbidities 
1 -  Tuberculosis 
2 -  Thyroid disorders 
3 -  Dyslipidemia 
4 -  Situs inversus 
5 -  CRF 
Wt :  Weight of patient in kg 
Height : Height of patient in cm 
BMI : Body mass index as weight / height2 
Hb :  Hemoglobin in gm% 
Seralb :  Serum albumin in mg/dl 
Levles : Level of lesion 
1 -  Middle third of esophagus 
2 -  Lower third of esophagus 
3 -  GE junction 
4 -  Proximal stomach 
Biopsy : Final biopsy report 
1 -  Well differentiated adenocarcinoma 
2 -  Moderately differentiated adenocarcinoma 
3 -  Poorly differentiated adenocarcinoma 
4 -  Squamopus cell carcinoma 
5 -  Lymphoma 
6 -  Schwannoma 
7 -  Leiomyoma/ GIST 
8 -  Not applicable 
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Surge: Type of Operation done 
1 -  Ivor Lewis esophagectomy 
2 -  McKeown’s esophagectomy 
3 -  Transhiatal esophagectomy 
4 -  Total gastrectomy 
5 -  Substernal colon bypass 
6 -  Distal esophagectomy + proximal gastrectomy 
DurSx / Dur Ax :  Duration of surgery and anaesthesia in minutes 
Components of anastomosis : 
1 -  Esophagoesophageal 
2 -  Esophagogastric 
3 -  Esophagojejunal 
4 -  Esophago colic  
Level of anastomosis :  
1 -  Upper third of esophagus 
2 -  Middle third of esophagus 
3 -  Lower third of esophagus 
Staple :  Use of stapled anastomosis 
0 -  Handsewn anastomosis 
1 -  Stapled anastomosis 
Hypox :  Presence of intraoperative hypoxia for more than 1 minute 
               0  -  No        1   - Yes 
Hypot :  Presence of intraoperative hypotension requiring inotropes 
                 0  -   No      1  -  Yes 
Blood loss :  Total intraoperative blood loss as evaluated by anaesthetist(ml) 
Transfuse : Number of units of blood transfused intraoperatively 
Ventd : Number of days on ventilator 
SICU :  Number of postoperative days in SICU 
ARD :  Occurrence of ARDS in the postoperative period  0  -  No     1  - Yes 
Fevers  :  Number of spikes of fever in the first 10 postoperative days 
Margp :  Margin positivity according to final biopsy report 
1  -  All margins free of tumor 
2  -  Proximal margin with tumor 
3  -  Distal margin with tumor 
4  -  Circumferential margin with tumor 
5  -  More than one margin with tumor 
DAStech : Discomfort analogue score after Technetium imaging (0-10) 
Techleak : Leak detected by Technetium scans   0  -  No      1  -  Yes 
DASBa : Discomfort analogue score after barium study (0-10) 
Barileak  :  Leak detected by barium study     0  -  No       1  -  Yes 
Clinleak :  Clinical diagnosis of leak     0  -  No    1  -  Yes 
 
 
 
 
 
 
 
